Telomir Pharmaceuticals
TELO
27 hedge funds and large institutions have $2.91M invested in Telomir Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 10 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
0.13% less ownership
Funds ownership: 6.65% → 6.52% (-0.13%)
4% less capital invested
Capital invested by funds: $3.04M → $2.91M (-$127K)
18% less funds holding
Funds holding: 33 → 27 (-6)
50% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$32.6K |
| 2 |
Goldman Sachs
New York
|
+$13.3K |
| 3 |
PWM
Praetorian Wealth Management
Carmel,
California
|
+$12.8K |
| 4 |
BlackRock
New York
|
+$4.78K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$2.55K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$48.4K |
| 2 |
VF
Virtu Financial
New York
|
-$19K |
| 3 |
Jane Street
New York
|
-$15.5K |
| 4 |
Mariner
Overland Park,
Kansas
|
-$15.5K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$13.3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SS
26
SBI Securities
Tokyo,
Japan
| $5 | – | – | – |
|
|
CIAM
27
Caitong International Asset Management
Hong Kong
| $3 | +$3 | +2 | New |
|
|
VF
28
Virtu Financial
New York
| – | -$19K | -14,278 | Closed |
|
|
29
Jane Street
New York
| – | -$15.5K | -11,677 | Closed |
|
|
30
Mariner
Overland Park,
Kansas
| – | -$15.5K | -11,631 | Closed |
|
|
TSS
31
Two Sigma Securities
New York
| – | -$13.3K | -10,004 | Closed |
|
|
IA
32
IFP Advisors
Tampa,
Florida
| – | -$3.99K | -3,000 | Closed |
|
|
FFO
33
Fortitude Family Office
Scottsdale,
Arizona
| – | -$1.79K | -1,347 | Closed |
|
|
EWA
34
EverSource Wealth Advisors
Birmingham,
Alabama
| – | -$504 | -379 | Closed |
|
35
Bank of America
Charlotte,
North Carolina
| – | -$30 | -23 | Closed |
|
36
Barclays
London,
United Kingdom
| – | -$3 | -2 | Closed |
|
37
Citigroup
New York
| – | -$1 | -1 | Closed |
|
TELO Hedge Fund Activity: Q1 2026 in Review
27 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in Telomir Pharmaceuticals (TELO) for Q1 2026, worth a combined $2.91M — down 4.2% from $3.04M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of TELO and 5 opened new positions — a net loss of 5 holders — while 3 trimmed existing stakes and 5 added.
The largest buyer was Geode Capital Management, adding an estimated $32.6K. The largest seller was Millennium Management, cutting an estimated $48.4K.
- 27 institutional investors held Telomir Pharmaceuticals (TELO) as of Q1 2026, down from 33 in Q4 2025.
- Funds reported $2.91M of Telomir Pharmaceuticals stock for Q1 2026, down 4.2% quarter-over-quarter.
- 5 funds opened new Telomir Pharmaceuticals positions in Q1 2026 and 10 closed out, a net change of -5 holders.
- The largest Telomir Pharmaceuticals buyer in Q1 2026 was Geode Capital Management, an estimated $32.6K added.
- The largest Telomir Pharmaceuticals seller in Q1 2026 was Millennium Management, an estimated $48.4K sold.
Based on aggregated 13F filings for Q1 2026.